Management of Bleeding in Cardiovascular Surgery / Edition 1 available in Paperback
- Pub. Date:
- Elsevier Health Sciences
This new book provides an up-to-date review of the most important developments and new agents employed to manage bleeding associated with all types of cardiovascular surgery. Specialists in the fields of anaesthesia, cardiology, and haematology share their expertise and insights on how postoperative bleeding can be prevented, reduced, or controlled. The importance of a team effort and knowledge of anticoagulation, hemostasis, and pharmacology is stressed in terms ofpreventing postoperative bleeding.
• Encompasses the viewpoints of various specialists involved with the control of bleeding.
|Publisher:||Elsevier Health Sciences|
|Product dimensions:||6.18(w) x 9.08(h) x 1.03(d)|
Table of Contents
Bleeding as a Complication of Cardiopulmonary Bypass. Thrombotic and Hemorrhagic Problems during Cardiovascular Bypass Surgery and Cardiovascular Procedures. Thrombosis and Hemostatis in Cardiology. The Impact of the Endothelial Cell on Coagulation in Cardiopulmonary Bypass.The Importance of Proper Anticoagulation and Heparin Neutralization in Cardiopulmonary Bypass. Monitoring Anticoagulants during Cardiopulmonary Bypass Surgery. Fibrinolytic Activation on Cardiopulmonary Bypass: Impact on the Management of Bleeding. Bleeding During and After Cardiopulmonary Bypass: A 15-Year Institutional Experience. Preoperative Blood Tests to Prevent Postoperative Bleeding: How Useful Are They? Bovine Lung Heparin vs. Porcine Intestinal Mucosal Heparin: Clinical Implications. Thrombelastographic Coagulation Monitoring During Cardiovascular Surgery with the ROTEG Coagulation Analyzer. Pharmacologic Management of Surgical Bleeding: Impact of Newer Antithrombotic and Anticoagulant Drugs. Efficacy and Safety of Aprotinin: The United States Clinical Trials, 1992-1998. Synthetic Antifibrinolytics and Aprotinin for Cardiac Surgery. Management of Heparin-Induced Thrombocytopenia and Postoperative Bleeding in Cardiovascular Surgery. Heparinase I (Neutralase TM) as a Potential Heparin Reversal Agent in Coronary Artery Bypass Surgery. Management of Bleeding in the Cardiac Catheterization Laboratory. Blood Components an Concentrates in the Management of Bleeding After Cardiopulmonary Bypass. Recombinant Factor VIIa (NovoSeven) in the Control of SurgicalBleeding. Bleeding Complications Associated with Percutaneous Coronary Interventions. Plasma Markers of Hemostatic Activation in Cardiac Patients. Inflammation Following Cardiopulmonary Bypass: The Post-Pump Syndrome. Control and Standardization of Anticoagulant Therapy. Antiplatelet Agents and Perioperative and Postoperative Bleeding in Cardiopulmonary Bypass. Apheresis in Cardiovascular Surgery. Platelets in Primary Hemostatic Components: Role in the Control of Surgical Bleeding. Postoperative Bleeding and Heart Transplantation: Theoretical and Practical Considerations. Control of Bleeding in Total Artificial Heart Implants. Bleeding Management in Cardiopulmonary Bypass Patients Anticoagulated with Orgaran. Long-Term Low-Molecular-Weight Heparin: Potential Use in Cardiopulmonary Bypass Surgery. Management of Surgical Bleeding in Cardiopulmonary Bypass Surgery.